{"Symbol": "ADMA", "AssetType": "Common Stock", "Name": "ADMA Biologics Inc", "Description": "ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures and markets plasma-derived biological products specialized for the treatment of immunodeficiencies and infectious diseases in the United States. The company is headquartered in Ramsey, New Jersey.", "CIK": "1368514", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "465 STATE ROUTE 17, RAMSEY, NJ, UNITED STATES, 07446", "OfficialSite": "https://www.admabiologics.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "3839568000", "EBITDA": "175009000", "PERatio": "18.71", "PEGRatio": "0", "BookValue": "1.809", "DividendPerShare": "None", "DividendYield": "None", "EPS": "0.86", "RevenuePerShareTTM": "2.053", "ProfitMargin": "0.429", "OperatingMarginTTM": "0.38", "ReturnOnAssetsTTM": "0.218", "ReturnOnEquityTTM": "0.632", "RevenueTTM": "488559000", "GrossProfitTTM": "267282000", "DilutedEPSTTM": "0.86", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0.12", "AnalystTargetPrice": "25.67", "AnalystRatingStrongBuy": "0", "AnalystRatingBuy": "3", "AnalystRatingHold": "0", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "18.71", "ForwardPE": "28.99", "PriceToSalesRatioTTM": "7.86", "PriceToBookRatio": "8.88", "EVToRevenue": "7.88", "EVToEBITDA": "22.37", "Beta": "0.483", "52WeekHigh": "25.67", "52WeekLow": "13.5", "50DayMovingAverage": "18.09", "200DayMovingAverage": "17.72", "SharesOutstanding": "237998000", "SharesFloat": "233252000", "PercentInsiders": "2.743", "PercentInstitutions": "95.943", "DividendDate": "None", "ExDividendDate": "None"}